ATE242241T1 - Imidazopyridinderivate und verfahren zu ihrer herstellung - Google Patents

Imidazopyridinderivate und verfahren zu ihrer herstellung

Info

Publication number
ATE242241T1
ATE242241T1 AT99203478T AT99203478T ATE242241T1 AT E242241 T1 ATE242241 T1 AT E242241T1 AT 99203478 T AT99203478 T AT 99203478T AT 99203478 T AT99203478 T AT 99203478T AT E242241 T1 ATE242241 T1 AT E242241T1
Authority
AT
Austria
Prior art keywords
production
imidazopyridine derivatives
chem
compound
formula
Prior art date
Application number
AT99203478T
Other languages
English (en)
Inventor
Gerrit Jan Bouke Ettema
Jacobus Maria Lemmens
Theodorus Hendricus Ant Peters
Frantisek Picha
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of ATE242241T1 publication Critical patent/ATE242241T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inert Electrodes (AREA)
AT99203478T 1999-03-25 1999-10-22 Imidazopyridinderivate und verfahren zu ihrer herstellung ATE242241T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12649499P 1999-03-25 1999-03-25

Publications (1)

Publication Number Publication Date
ATE242241T1 true ATE242241T1 (de) 2003-06-15

Family

ID=22425138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99203478T ATE242241T1 (de) 1999-03-25 1999-10-22 Imidazopyridinderivate und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (2) US6242460B1 (de)
EP (1) EP1038875B1 (de)
AT (1) ATE242241T1 (de)
DE (1) DE69908546T2 (de)
DK (1) DK1038875T3 (de)
ES (1) ES2195510T3 (de)
PT (1) PT1038875E (de)
SI (1) SI1038875T1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078725A2 (en) * 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
EP1475093B1 (de) * 2000-04-24 2006-09-06 Teva Pharmaceutical Industries Ltd. Mikronisierter zolpidem Hemitartrat
IL152411A0 (en) * 2000-04-24 2003-05-29 Teva Pharma Zolpidem hemitartrate
US20030165566A1 (en) * 2002-01-10 2003-09-04 O'toole Edel Sedative non-benzodiazepine formulations
WO2004058758A1 (en) * 2002-12-18 2004-07-15 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
GB0329918D0 (en) * 2003-12-24 2004-01-28 West Pharm Serv Drug Res Ltd Intranasal compositions
KR20070030178A (ko) * 2004-02-17 2007-03-15 트랜스오랄 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
US20080262025A1 (en) * 2004-07-16 2008-10-23 Yatendra Kumar Processes for the Preparation of Zolpidem and its Hemitartrate
BRPI0609984A2 (pt) * 2005-05-25 2010-05-18 Transcept Pharmaceuticals Inc uso de zolpidem ou um sal do mesmo
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
CN101291654A (zh) * 2005-10-17 2008-10-22 马林克罗特公司 片剂基质中唑吡坦的多晶型转化
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
WO2007065559A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
US7989207B2 (en) * 2006-02-17 2011-08-02 Tyco Healthcare Group Lp Testing lumenectomy samples for markers of non-vascular diseases
ATE478067T1 (de) 2006-03-31 2010-09-15 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyridine und pyrazine als modulatoren des histamin-h4-rezeptors
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
JO3516B1 (ar) * 2013-03-06 2020-07-05 Janssen Pharmaceutica Nv مُعدِّلات بنزإيميدازول-2-يل بيريميدين لمستقبل الهستامين h4
CN104610253B (zh) * 2015-01-26 2016-11-16 郑州大学 2‑三氟甲基‑2‑羟基‑2‑(2‑芳基吡啶并[1,2‑α]咪唑)乙酸酯类化合物
CN106432233B (zh) * 2016-09-20 2018-08-14 华东理工大学 N,N,6-三甲基-2-(4-甲基苯基)咪唑并[1,2-a]吡啶-3-乙酰胺的制备方法
EP3611256A1 (de) * 2018-08-14 2020-02-19 Universität Heidelberg Verwendung von imidazopyridinderivaten in der regenerativen medizin
CN116217565B (zh) * 2021-12-03 2026-03-17 山东新时代药业有限公司 唑吡坦盐及其制备方法
CN116283958B (zh) * 2021-12-03 2026-02-24 山东新时代药业有限公司 唑吡坦共晶体及其制备方法
CN116283957A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦水合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2600650B1 (fr) 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires

Also Published As

Publication number Publication date
US6281360B1 (en) 2001-08-28
ES2195510T3 (es) 2003-12-01
DE69908546D1 (de) 2003-07-10
PT1038875E (pt) 2003-10-31
DK1038875T3 (da) 2003-09-29
US6242460B1 (en) 2001-06-05
DE69908546T2 (de) 2004-04-29
EP1038875A2 (de) 2000-09-27
EP1038875B1 (de) 2003-06-04
EP1038875A3 (de) 2001-09-12
SI1038875T1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
DE69908546D1 (de) Imidazopyridinderivate und Verfahren zu ihrer Herstellung
ATE229527T1 (de) Pyrazolopyridylpyrazinon-derivate und ein verfahren zu ihrer herstellung
DE69524251D1 (de) Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
ATE201687T1 (de) Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament
FI101226B1 (fi) Menetelmä lääkeaineena käyttökelpoisten 2-[2-(karbonyyli)pyrrolidin-4-yylitio]-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi
EP1123918A4 (de) Aromatische aminderivate, verfahren zu ihrer herstellung und mittel, die diese enthalten
ATE227703T1 (de) Aminotetralon-derivate und verfahren zu deren herstellung
ATE253577T1 (de) Neue wasserlösliche fluoroethylcamptothecin- derivate und ein verfahren zu ihrer herstellung
ATE95177T1 (de) Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
DE59905818D1 (de) Verfahren zur Herstellung von O-Alkylisoharnstoff
ATE336482T1 (de) Zwischenprodukte zur synthese von benzimidazolverbindungen und ein verfahren zu ihrer herstellung
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
DE60040653D1 (de) Carbonsäurederivate und verfahren zu ihrer herstellung
DE60009893D1 (de) Benzoxazol-derivate, verfahren zu ihrer herstellung und herbizide
ATE225350T1 (de) Verfahren zur herstellung von folsäure
DE69909646D1 (de) Derivate der aminoacryl-säure und ein verfahren zur herstellung derselben
ATE346845T1 (de) Ein verfahren zur herstellung substituierter alkylamin-derivate
EP1219610A4 (de) Verfahren zur herstellung von oxazol-derivaten
ATE254623T1 (de) Vitamin-d-vorlaüferverbindungen, verfahren und intermediären zu deren herstellung
ATE249434T1 (de) Ein verfahren zur herstellung von pyrrolidinon- derivaten
ATE329917T1 (de) 1h-pyrrolo 1,2-bö 1,2,4ötriazolederivate, zwischenprodukte und verfahren zur herstellung von 1h-1,2,4,-triazol-5-yl essigsäureesterderivate
ATE258545T1 (de) Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen
ATE396975T1 (de) 5-aminopyrazol-4-carboxylat derivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1038875

Country of ref document: EP

REN Ceased due to non-payment of the annual fee